en

PRODUCT DETAIL

Tenkasi 400 mg prášok na prípravu infúzneho koncentrátu

Code 4083B
MA number EU/1/15/989/001
Product Form: plc ifc 3x400 mg (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Menarini International Operations Luxembourg S.A., Luxembourg
Therapeutic Class: 15 - ANTIBIOTICA (PROTI MIKROB. A VÍRUSOVÝM INFEKCIAM)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01X OTHER ANTIBACTERIALS
J01XA Glycopeptide antibacterials
J01XA05 Oritavancin
Shelf life: 48
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 19.03.2015
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 30.05.2023
eu-flag.png sk-flag.png